eIF4A3-IN-18 can be used in the study of human tumorigenesis; it disrupts eIF4F translation complex assembly and exhibits potent inhibitory activity against myc-LUC (EC50 = 0.8 nM), tub-LUC (EC50 = 35 nM), and MDA-MB-231 cell growth (EC50 = 2 nM); it also shows cytotoxicity against RPMI-8226 cells (LC50 = 0.06 nM).